Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial disorders.

M Zeviani1, T Klopstock

  • 1Unit of Biochemistry and Genetics, National Neurological Institute C. Besta, Milan, Italy. zeviani@tin.it

Current Opinion in Neurology
|September 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain Abnormalities in Patients with Germline Variants in <i>H3F3</i>: Novel Imaging Findings and Neurologic Symptoms Beyond Somatic Variants and Brain Tumors.

AJNR. American journal of neuroradiology·2022
Same author

Strategies for fighting mitochondrial diseases.

Journal of internal medicine·2020
Same author

SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype.

Biochimica et biophysica acta. Molecular basis of disease·2018
Same author

AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome.

Gene therapy·2017
Same author

Revisiting mitochondrial ocular myopathies: a study from the Italian Network.

Journal of neurology·2017
Same author

[Risk genes in myopathies and mitochondrial diseases].

Der Nervenarzt·2017
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Mitochondrial DNA mutations explain only some mitochondrial disorders. Research now focuses on nuclear genes, revealing their critical role in oxidative phosphorylation and offering new therapeutic avenues.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Mitochondrial DNA (mtDNA) mutations are a known cause of mitochondrial disorders.
  • However, mtDNA mutations account for only a fraction of these complex genetic conditions.
  • Emerging evidence points to nuclear genes playing a significant role in mitochondrial function and disease.

Purpose of the Study:

  • To highlight the importance of nuclear genes in mitochondrial disorders.
  • To explain the slower pace of nuclear gene discovery compared to mtDNA mutations.
  • To discuss recent advancements and future directions in identifying nuclear genes involved in oxidative phosphorylation.

Main Methods:

  • Review of clinical and molecular observations linking nuclear gene abnormalities to mitochondrial disorders.

Related Experiment Videos

  • Analysis of the challenges in identifying nuclear genes responsible for oxidative phosphorylation defects.
  • Discussion of the impact of newly discovered human oxidative phosphorylation genes and animal models.

    • Main Results:

    • Known mtDNA mutations explain only a portion of mitochondrial disorders.
    • Nuclear genes encode numerous proteins essential for mitochondrial biogenesis and oxidative phosphorylation.
    • Several oxidative phosphorylation-related human genes have recently been identified, with mutations linked to clinical syndromes.

    Conclusions:

    • Nuclear gene defects are a significant, previously underappreciated cause of mitochondrial disorders.
    • Recent discoveries are rapidly advancing our understanding of the nuclear gene repertoire in humans.
    • Animal models are crucial for elucidating pathogenesis and developing therapeutic strategies for oxidative phosphorylation defects.